
|Videos|December 20, 2022
Interview with Anthony Carpanzano (AAPS 2022)
Author(s)Chris Spivey
Anthony Carpanzano, Director of R&D at JRS Pharma, discussed ongoing formulation challenges and trends.
KEY LEARNING OBJECTIVES
- Overcoming formulation challenges in converting liquids into solid dose,
- Turning soft gel into tablets, enhancing dissolution,
- Simplifying modified-release formulations
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
4
Behind the Headlines Episode 31: Optimism, Opportunity, Optimization of COGs & Organizational Streamlining
5




